Body Vision Medical recently entered a partnership with Business Asia Consultants as it pursues a global expansion.
"We are excited about the opportunity to help facilitate Body Vision's expansion into international markets," Larry Kronick, president of BAC Inc., said in a recent press release. "With our team of associates, we are uniquely qualified and positioned to work closely with the Body Vision team to develop new markets that will benefit patients and health care providers alike."
Established in 2014, Body Vision Medical's specializes in AI-driven, intraoperative imaging, offering health-related systems, such as its first commercial product, LungVision, to “empower bronchoscopists to biopsy from smaller, more difficult-to-access lung lesions at an earlier stage, thus maximizing the likelihood of an early diagnosis for lung cancer patients and improving odds for survival,” a recent press release explains.
The company’s LungVision system was approved and cleared by the FDA in 2019 and received its CE Mark just last year.
"As global economic growth slows, health care institutions everywhere are increasingly looking at how to enable their existing medical staff to deliver superior clinical outcomes and patient experience at a lower cost," David Webster, CEO of Body Vision Medical, said. "Body Vision's LungVision system is uniquely positioned to help health care institutions deliver on these quadruple aims of health care in a cost-effective manner but in order for health care organizations globally to benefit from our imaging technology, we need to ensure that they have access to it. Expanding into 60 markets over the next three years is an aggressive goal, but by working with best-of-breed partners like BAC we believe this is infinitely achievable."